GT Biopharma (GTBP) Non-Current Debt (2011 - 2021)
GT Biopharma (GTBP) posted quarterly Non-Current Debt of $31000.0 for Q3 2021, little changed year-over-year from $31000.0 in Q3 2020, and little changed quarter-over-quarter from $31000.0 in Q2 2021.
GT Biopharma (GTBP) Non-Current Debt (2011 - 2021) Analysis & Trends
GT Biopharma (GTBP) has reported Non-Current Debt for 11 consecutive years, with $31000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Non-Current Debt changed 0.0% year-over-year to $31000.0; the TTM figure through Sep 2021 stood at $31000.0 (changed 0.0% YoY), while the FY2020 annual figure was $31000.0, changed 0.0% from the prior year.
- Non-Current Debt was little changed at $31000.0 in Q3 2021 per GTBP's latest filing, from $31000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $31000.0 in Q1 2017 and bottomed at $31000.0 in Q1 2017.
- Historically, Non-Current Debt has averaged $31000.0 across 5 years, with a median of $31000.0 in 2017.
- On a YoY basis, Non-Current Debt climbed as much as 0.0% in 2017 and fell as far as 0.0% in 2017.
- GT Biopharma's Non-Current Debt stood at $31000.0 in 2017, then changed by 0.0% to $31000.0 in 2018, then changed by 0.0% to $31000.0 in 2019, then changed by 0.0% to $31000.0 in 2020, then changed by 0.0% to $31000.0 in 2021.
- Business Quant data shows GTBP's Non-Current Debt at $31000.0 in Q3 2021, $31000.0 in Q2 2021, and $31000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 8.96 Bn |
| 10 | GT Biopharma | 8.81 Mn | 8.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 31,000.00 |
| Mar 31, 2021 | 31,000.00 |
| Dec 31, 2020 | 31,000.00 |
| Sep 30, 2020 | 31,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 31,000.00 |
| Sep 30, 2019 | 31,000.00 |
| Jun 30, 2019 | 31,000.00 |
| Mar 31, 2019 | 31,000.00 |
| Dec 31, 2018 | 31,000.00 |
| Sep 30, 2018 | 31,000.00 |
| Jun 30, 2018 | 31,000.00 |
| Mar 31, 2018 | 31,000.00 |
| Dec 31, 2017 | 31,000.00 |
| Sep 30, 2017 | 31,000.00 |
| Jun 30, 2017 | 31,000.00 |
| Mar 31, 2017 | 31,000.00 |
| Dec 31, 2016 | 31,000.00 |